US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist
  • 0.8490
  • 0.00000.00%
Close Aug 14 16:00 ET
  • 0.8500
  • +0.0010+0.12%
Post 20:02 ET
4.15MMarket Cap-64P/E (TTM)

Virpax Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-87.36%1.87M
-89.01%1.87M
-51.87%9.14M
-51.87%9.14M
-40.90%12.15M
-43.20%14.8M
-44.84%16.99M
-48.44%19M
-48.44%19M
-50.71%20.56M
-Cash and cash equivalents
-87.36%1.87M
-89.01%1.87M
-51.87%9.14M
-51.87%9.14M
-40.90%12.15M
-43.20%14.8M
-44.84%16.99M
-48.44%19M
-48.44%19M
-50.71%20.56M
Prepaid assets
-44.50%611.74K
26.83%1.18M
-35.74%419.61K
-35.74%419.61K
78.20%855.28K
45.45%1.1M
-19.13%932.69K
155.24%653.02K
155.24%653.02K
4.56%479.97K
Other current assets
139.90%108.14K
-85.83%81.31K
165.27%67.22K
165.27%67.22K
-98.84%30.11K
-98.26%45.08K
-79.48%573.74K
-98.98%25.34K
-98.98%25.34K
135.62%2.59M
Total current assets
-83.76%2.59M
-83.07%3.13M
-51.06%9.63M
-51.06%9.63M
-44.84%13.04M
-45.75%15.95M
-46.78%18.49M
-50.28%19.67M
-50.28%19.67M
-45.38%23.64M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-83.76%2.59M
-83.07%3.13M
-51.06%9.63M
-51.06%9.63M
-44.84%13.04M
-45.75%15.95M
-46.78%18.49M
-50.28%19.67M
-50.28%19.67M
-45.38%23.64M
Liabilities
Current liabilities
Payables
-0.87%75.4K
-70.66%13.28K
-50.97%18.46K
-50.97%18.46K
131.77%33.19K
169.35%76.06K
335.06%45.25K
89.73%37.64K
89.73%37.64K
2,408.06%14.32K
-Total tax payable
----
----
----
----
----
----
----
----
----
--0
-Other payable
-0.87%75.4K
-70.66%13.28K
-50.97%18.46K
-50.97%18.46K
131.77%33.19K
275.82%76.06K
335.06%45.25K
89.73%37.64K
89.73%37.64K
2,408.06%14.32K
Current accrued expenses
110.20%2.81M
46.56%1.83M
58.53%1.68M
58.53%1.68M
-65.64%1.44M
-45.55%1.34M
-42.61%1.25M
-48.89%1.06M
-48.89%1.06M
140.82%4.19M
Other current liabilities
25.00%2.5M
25.00%2.5M
200.00%6M
200.00%6M
--5M
--2M
--2M
--2M
--2M
----
Current liabilities
47.67%5.39M
31.86%4.34M
148.63%7.69M
148.63%7.69M
55.25%6.53M
46.85%3.65M
50.64%3.29M
48.23%3.09M
48.23%3.09M
132.25%4.21M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
47.67%5.39M
31.86%4.34M
148.63%7.69M
148.63%7.69M
55.25%6.53M
46.85%3.65M
50.64%3.29M
48.23%3.09M
48.23%3.09M
132.25%4.21M
Shareholders'equity
Share capital
-76.07%28
-89.74%12
0.00%12
0.00%12
0.00%117
0.00%117
0.00%117
-89.74%12
-89.74%12
0.00%117
-common stock
-76.07%28
-89.74%12
0.00%12
0.00%12
0.00%117
0.00%117
0.00%117
-89.74%12
-89.74%12
0.00%117
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-35.17%-66.21M
-36.82%-62.76M
-34.25%-59.54M
-34.25%-59.54M
-32.91%-54.98M
-45.25%-48.99M
-64.78%-45.88M
-95.36%-44.35M
-95.36%-44.35M
-122.57%-41.37M
Paid-in capital
3.47%63.42M
0.78%61.55M
0.89%61.48M
0.89%61.48M
1.14%61.49M
1.07%61.29M
1.12%61.07M
1.24%60.93M
1.24%60.93M
1.25%60.8M
Total stockholders'equity
-122.71%-2.79M
-107.98%-1.21M
-88.33%1.93M
-88.33%1.93M
-66.51%6.51M
-54.29%12.3M
-53.32%15.2M
-55.77%16.58M
-55.77%16.58M
-53.14%19.43M
Total equity
-122.71%-2.79M
-107.98%-1.21M
-88.33%1.93M
-88.33%1.93M
-66.51%6.51M
-54.29%12.3M
-53.32%15.2M
-55.77%16.58M
-55.77%16.58M
-53.14%19.43M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -87.36%1.87M-89.01%1.87M-51.87%9.14M-51.87%9.14M-40.90%12.15M-43.20%14.8M-44.84%16.99M-48.44%19M-48.44%19M-50.71%20.56M
-Cash and cash equivalents -87.36%1.87M-89.01%1.87M-51.87%9.14M-51.87%9.14M-40.90%12.15M-43.20%14.8M-44.84%16.99M-48.44%19M-48.44%19M-50.71%20.56M
Prepaid assets -44.50%611.74K26.83%1.18M-35.74%419.61K-35.74%419.61K78.20%855.28K45.45%1.1M-19.13%932.69K155.24%653.02K155.24%653.02K4.56%479.97K
Other current assets 139.90%108.14K-85.83%81.31K165.27%67.22K165.27%67.22K-98.84%30.11K-98.26%45.08K-79.48%573.74K-98.98%25.34K-98.98%25.34K135.62%2.59M
Total current assets -83.76%2.59M-83.07%3.13M-51.06%9.63M-51.06%9.63M-44.84%13.04M-45.75%15.95M-46.78%18.49M-50.28%19.67M-50.28%19.67M-45.38%23.64M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -83.76%2.59M-83.07%3.13M-51.06%9.63M-51.06%9.63M-44.84%13.04M-45.75%15.95M-46.78%18.49M-50.28%19.67M-50.28%19.67M-45.38%23.64M
Liabilities
Current liabilities
Payables -0.87%75.4K-70.66%13.28K-50.97%18.46K-50.97%18.46K131.77%33.19K169.35%76.06K335.06%45.25K89.73%37.64K89.73%37.64K2,408.06%14.32K
-Total tax payable --------------------------------------0
-Other payable -0.87%75.4K-70.66%13.28K-50.97%18.46K-50.97%18.46K131.77%33.19K275.82%76.06K335.06%45.25K89.73%37.64K89.73%37.64K2,408.06%14.32K
Current accrued expenses 110.20%2.81M46.56%1.83M58.53%1.68M58.53%1.68M-65.64%1.44M-45.55%1.34M-42.61%1.25M-48.89%1.06M-48.89%1.06M140.82%4.19M
Other current liabilities 25.00%2.5M25.00%2.5M200.00%6M200.00%6M--5M--2M--2M--2M--2M----
Current liabilities 47.67%5.39M31.86%4.34M148.63%7.69M148.63%7.69M55.25%6.53M46.85%3.65M50.64%3.29M48.23%3.09M48.23%3.09M132.25%4.21M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 47.67%5.39M31.86%4.34M148.63%7.69M148.63%7.69M55.25%6.53M46.85%3.65M50.64%3.29M48.23%3.09M48.23%3.09M132.25%4.21M
Shareholders'equity
Share capital -76.07%28-89.74%120.00%120.00%120.00%1170.00%1170.00%117-89.74%12-89.74%120.00%117
-common stock -76.07%28-89.74%120.00%120.00%120.00%1170.00%1170.00%117-89.74%12-89.74%120.00%117
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -35.17%-66.21M-36.82%-62.76M-34.25%-59.54M-34.25%-59.54M-32.91%-54.98M-45.25%-48.99M-64.78%-45.88M-95.36%-44.35M-95.36%-44.35M-122.57%-41.37M
Paid-in capital 3.47%63.42M0.78%61.55M0.89%61.48M0.89%61.48M1.14%61.49M1.07%61.29M1.12%61.07M1.24%60.93M1.24%60.93M1.25%60.8M
Total stockholders'equity -122.71%-2.79M-107.98%-1.21M-88.33%1.93M-88.33%1.93M-66.51%6.51M-54.29%12.3M-53.32%15.2M-55.77%16.58M-55.77%16.58M-53.14%19.43M
Total equity -122.71%-2.79M-107.98%-1.21M-88.33%1.93M-88.33%1.93M-66.51%6.51M-54.29%12.3M-53.32%15.2M-55.77%16.58M-55.77%16.58M-53.14%19.43M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg